-
Making Strides Toward Off-the-Shelf CAR T Cell Therapy for Cancer
Feb 02 2025 -
Beacon Therapeutics Achieves Major Milestone with FDA RMAT Designation for XLRP Treatment
Jan 31 2025 -
Allogene Therapeutics Announces FDA Clearance of IND Application for Rheumatology Basket Study
Jan 31 2025 -
Sarepta Therapeutics Announces EMBARK Study Part 2 Results
Jan 31 2025 -
NHS England to offer Casgevy for sickle cell disease patients
Jan 31 2025 -
Tessera Therapeutics Advances In Vivo Gene Therapy For SCD
Jan 30 2025 -
IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Singapore Health Sciences Authority (HSA)
Jan 29 2025 -
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
Jan 29 2025 -
Cartesian Therapeutics announces FDA agreement for new trial
Jan 28 2025